ATE440848T1 - Synthese von proteaseinhibitorvorstufen - Google Patents

Synthese von proteaseinhibitorvorstufen

Info

Publication number
ATE440848T1
ATE440848T1 AT06724879T AT06724879T ATE440848T1 AT E440848 T1 ATE440848 T1 AT E440848T1 AT 06724879 T AT06724879 T AT 06724879T AT 06724879 T AT06724879 T AT 06724879T AT E440848 T1 ATE440848 T1 AT E440848T1
Authority
AT
Austria
Prior art keywords
synthesis
protease inhibitor
inhibitor precursors
precursors
processes
Prior art date
Application number
AT06724879T
Other languages
English (en)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE440848T1 publication Critical patent/ATE440848T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT06724879T 2005-02-25 2006-02-24 Synthese von proteaseinhibitorvorstufen ATE440848T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (en) 2005-02-25 2006-02-24 Protease inhibitor precursor synthesis

Publications (1)

Publication Number Publication Date
ATE440848T1 true ATE440848T1 (de) 2009-09-15

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724879T ATE440848T1 (de) 2005-02-25 2006-02-24 Synthese von proteaseinhibitorvorstufen

Country Status (19)

Country Link
US (2) US8067463B2 (de)
EP (1) EP1856125B1 (de)
JP (1) JP5260965B2 (de)
KR (1) KR101333627B1 (de)
CN (1) CN101128469B (de)
AT (1) ATE440848T1 (de)
AU (1) AU2006217922B2 (de)
BR (1) BRPI0607827B8 (de)
CA (1) CA2595295C (de)
DE (1) DE602006008751D1 (de)
DK (1) DK1856125T3 (de)
ES (1) ES2331257T3 (de)
IL (1) IL184519A (de)
MX (1) MX2007010378A (de)
NO (1) NO20074880L (de)
PL (1) PL1856125T3 (de)
PT (1) PT1856125E (de)
RU (1) RU2421459C2 (de)
WO (1) WO2006089942A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
WO2012075122A2 (en) * 2010-11-30 2012-06-07 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2362404T5 (es) 1998-06-23 2015-11-25 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Ensayo de aptitud y métodos para reducir la resistencia del VIH a terapia
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EP1089328A1 (de) * 1999-09-29 2001-04-04 Infineon Technologies AG Verfahren zur Herstellung eines Halbleiterbauelementes
WO2001025240A1 (en) 1999-10-06 2001-04-12 Tibotec Pharmaceuticals Ltd. HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR
SI1370543T1 (sl) 2001-02-14 2007-04-30 Tibotec Pharm Ltd Sirokospektralni 2-(substituirani-amino)-benzotiazol sulfonamidni inhibitorji HIV proteaze
EE05384B1 (et) 2001-04-09 2011-02-15 Tibotec�Pharmaceuticals�Ltd. LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks
CZ304524B6 (cs) 2001-05-11 2014-06-18 Tibotec Pharmaceuticals Ltd. Derivát 2-aminobenzoxazolsulfonamidu, farmaceutická kompozice s jeho obsahem a léčivo pro léčení infekce retroviry
EP1265073A3 (de) 2001-06-05 2003-11-26 Tibotec Pharmaceuticals Ltd. Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
PL216539B1 (pl) 2001-12-21 2014-04-30 Tibotec Pharm Ltd Związki fenylosulfonylowe i zastosowanie związków fenylosulfonylowych
AU2003202914A1 (en) 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
CA2474671A1 (en) 2002-02-22 2003-08-28 Tibotec Bvba Methods for determining the influence of protein binding on antiretroviral activity
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
UA80819C2 (en) 2002-04-26 2007-11-12 Gilead Sciences Inc Phosphonate analogs of compounds inhibiting hiv proteases, pharmaceutical composition on their basis and their use
PT2767539T (pt) 2002-05-16 2017-08-28 Janssen Sciences Ireland Uc Formas pseudopolimórficas de um inibidor de protease de hiv
ES2292976T3 (es) 2002-05-17 2008-03-16 Tibotec Pharmaceuticals Ltd. Inhibidores de amplio espectro de tipo bencisoxazol-sulfonamida sustituida de la proteasa del vih.
EP1520247B1 (de) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutationsprofile bei mit phänotypischer medikamentenresistenz korrelierter hiv-1-protease

Also Published As

Publication number Publication date
WO2006089942A1 (en) 2006-08-31
DE602006008751D1 (de) 2009-10-08
KR20080005183A (ko) 2008-01-10
RU2007135345A (ru) 2009-03-27
US20120041215A1 (en) 2012-02-16
US8183394B2 (en) 2012-05-22
BRPI0607827A2 (pt) 2009-10-06
WO2006089942A8 (en) 2007-12-13
EP1856125B1 (de) 2009-08-26
NO20074880L (no) 2007-09-25
PL1856125T3 (pl) 2010-01-29
AU2006217922B2 (en) 2012-04-05
DK1856125T3 (da) 2009-12-07
MX2007010378A (es) 2007-09-25
AU2006217922A1 (en) 2006-08-31
CN101128469A (zh) 2008-02-20
US8067463B2 (en) 2011-11-29
BRPI0607827B1 (pt) 2019-11-05
CN101128469B (zh) 2012-11-14
RU2421459C2 (ru) 2011-06-20
CA2595295C (en) 2014-07-08
CA2595295A1 (en) 2006-08-31
JP5260965B2 (ja) 2013-08-14
US20090054668A1 (en) 2009-02-26
ES2331257T3 (es) 2009-12-28
PT1856125E (pt) 2009-11-06
EP1856125A1 (de) 2007-11-21
KR101333627B1 (ko) 2013-11-27
IL184519A0 (en) 2007-10-31
JP2008531522A (ja) 2008-08-14
IL184519A (en) 2012-01-31
BRPI0607827B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
TW200640914A (en) Novel processes for the preparation of a benzofuran
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
GEP20063955B (en) New process for the synthesis of (7-methoxy-3,4-dihydro-1-nap hthalenyl) acetonitrile and its application in the synthesis of agomelatine
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
DE602006019870D1 (de) Verfahren zur synthese von triazolen
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
NO20051867D0 (no) Fremgangsmate for fremstilling av intermediater
ATE440848T1 (de) Synthese von proteaseinhibitorvorstufen
BRPI0513778A (pt) processo para a preparação de compostos, e, uso dos compostos
ATE464280T1 (de) Synthese von idarubin-aglycon
ATE546451T1 (de) Cyclopropancarbonsäureester von acyclovir
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
TW200738731A (en) Substituted aminophenylsulfonamide compounds and derivatives as HIV protease inhibitor
TH103186B (th) โปรดรักเอไมด์ของเจมไซทาบีน, สารผสมและการใช้ของสิ่งนั้น
TH103186A (de)
DK1268441T3 (da) Mellemprodukt og fremgangsmåde til dets syntese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1856125

Country of ref document: EP